Omeros Corporation
NASDAQ:OMERBiotechnology
Healthcare
$14.55 +4.46%
+$0.43 today
- Market cap
- $1.08B
- Beta
- 2.53
- P/E (TTM)
- 8.4
- EPS (TTM)
- $1.20
52W Low $2.95High $17.65
Volume 2.53M
Average 1.55M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$116.09M
FY 2025 · Annual
Investing Cash Flow
$164.52M
FY 2025 · Annual
+100.1% YoYFinancing Cash Flow
-$42.17M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (191.55M) | (182.03M) | (117.81M) | (156.82M) | (3.35M) |
| Depreciation & Amortization | 1.39M | 952K | 920K | 950K | 964K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 11.65M | 10.49M | 8.19M |
| Change in Working Capital | (14.11M) | (118.97M) | 247.42M | 29.74M | 33.72M |
| Accounts Receivables | (34.31M) | (175.07M) | 245.72M | 40.01M | 30.45M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 14.64M | (10.67M) | 0 | 0 | 0 |
| Other Working Capital | 5.57M | 66.76M | 1.7M | (10.27M) | 3.27M |
| Other Non-Cash Items | 94.54M | 213.56M | (67.46M) | (33.17M) | (155.62M) |
| Operating Cash Flow | (109.72M) | (86.48M) | 74.73M | (148.8M) | (116.09M) |
| Capital Expenditures | (277K) | (113K) | (426K) | (165K) | (65K) |
| Acquisitions (Net) | 125.99M | 0 | 0 | 0 | 0 |
| Purchases of Investments | (32.01M) | (429.05M) | (1.02B) | (987.39M) | (185.31M) |
| Sales of Investments | 100M | 301.59M | 1.05B | 1.07B | 109.9M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 240M |
| Investing Cash Flow | 193.71M | (127.56M) | 27.45M | 82.22M | 164.52M |
| Debt Repayment | (1.82M) | 123.83M | (101.58M) | (41.34M) | (89.16M) |
| Common Stock Issued | 8.38M | 415K | 0 | 0 | 46.99M |
| Common Stock Repurchased | 0 | 0 | (4.65M) | (11.85M) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (241K) | 0 | 150K | 116.07M | 0 |
| Financing Cash Flow | 6.32M | 124.25M | (106.08M) | 62.88M | (42.17M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 90.31M | (89.8M) | (3.9M) | (3.71M) | 6.26M |
| Free Cash Flow | (110M) | (86.6M) | 74.3M | (148.97M) | (116.16M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$3.4M
+ D&A$964.0K
+ Stock-Based Comp$8.2M
+ Deferred Tax$0
+ Working Capital$33.7M
- Other Non-Cash-$155.6M
= Operating Cash Flow-$116.1M
- Capex-$65.0K
= Free Cash Flow-$116.2M
Analysis
FY2025 free cash flow is -$116.2M. FCF conversion is 3467.4% of net income. Operating cash flow was -$116.1M, with capex of -$65.0K. The largest bridge item is Other Non-Cash at -$155.6M.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Oct 30, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 30, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 24, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 1, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 28, 2026 |
Does OMER generate free cash flow?
Omeros Corporation (OMER) generated -$116.16M of free cash flow in fiscal 2025.
How much operating cash flow does OMER produce?
Operating cash flow was -$116.09M, before capital expenditures of $65,000.00.
Continue the stock analysis
Jump to another research area for this company.